Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone (Q44183076)
Jump to navigation
Jump to search
scientific article published on 15 October 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone |
scientific article published on 15 October 2002 |
Statements
1 reference
Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone (English)
1 reference
Nianning Qi
1 reference
Ludmila Kazdova
1 reference
Vaclav Zidek
1 reference
Vladimir Landa
1 reference
Vladimir Kren
1 reference
Harrihar A Pershadsingh
1 reference
Elizabeth St Lezin
1 reference
Nada A Abumrad
1 reference
Michal Pravenec
1 reference
Theodore W Kurtz
1 reference
15 October 2002
1 reference
1 reference
277
1 reference
50
1 reference
48501-48507
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference